| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 08/24/2006 | WO2006004774A3 Laulimalide analogues as therapeutic agents |
| 08/24/2006 | US20060189809 Method for the synthesis of quinoline derivatives |
| 08/24/2006 | US20060189674 Deacetylase inhibitors |
| 08/24/2006 | US20060189622 Pyridazinone and triazinone compounds and use thereof as pharmaceutical preparations |
| 08/24/2006 | US20060189615 2-Phenyl substituted imidazotriazinones as phosphodiesterase inhibitors |
| 08/24/2006 | US20060189604 Gramnegative and Grampositive bacterial infections; substituted Piperidine derivatives specially optionally substituted pyrido [3,2, -b][1,4] thiazin-yl; 6-({(3R,4S)-3-Fluoro-1-[(R)-2-hydroxy-2-(2-methoxy-quinolin-8-yl)-ethyl]-piperidin-4-ylamino }-methyl)-4H-pyrido[3,2-b][1,4]thiazin-3-one; nontoxic |
| 08/24/2006 | US20060189601 Antibacterial agents |
| 08/24/2006 | US20060189597 Lactam compounds and pharmaceutical use thereof |
| 08/24/2006 | US20060189544 Integrin-Mediated drug targeting |
| 08/24/2006 | US20060188943 For ultrahigh throughput assays; combinatorial libraries; solid phase synthesis; drug screening |
| 08/24/2006 | DE102005008021A1 New spiroketal-substituted cyclic ketoenol compounds used for combating animal parasites, undesired plant growth and/or undesired microorganisms |
| 08/24/2006 | CA2596015A1 Fused heterocyclic compounds useful as inhibitors of histone deacetylase |
| 08/23/2006 | EP1693369A1 Protein modifier production inhibitor |
| 08/23/2006 | EP1692142A1 Process for preparing amide acetals |
| 08/23/2006 | EP1692140A1 Compositions useful as inhibitors of protein kinases |
| 08/23/2006 | EP1692139A1 5,6 -dihydroxy-isoindole derivatives as linkers for oligomer solid phase synthesis |
| 08/23/2006 | EP1692138A1 Pyrano-quinolines, pyrano-quinolinones, combinations thereof, photochromic compositions and articles |
| 08/23/2006 | EP1692136A2 Azepinoindole derivatives as pharmaceutical agents |
| 08/23/2006 | EP1692124A1 Biaryl sulfonamides as mmp inhibitors |
| 08/23/2006 | EP1669357A8 Substance which exhibits antiviral and antibacterial activity and is based on derivatives of 2,8-dithioxo-1h-pyrano[ 2,3-d,6,5-d'] dipyrimidine and 10-aza-analogue thereof |
| 08/23/2006 | EP1648923A4 Spatially-defined macrocycles incorporating peptide bond surrogates |
| 08/23/2006 | EP1539133B1 Aminocyclohexene quinolines and their azaisosteric analogues with antibacterial activity |
| 08/23/2006 | EP1401445B1 Crystalline anticholinergic, method for its production, and use thereof in the production of a drug |
| 08/23/2006 | EP1278747B1 Pyrano, piperidino, and thiopyrano compounds and methods of use |
| 08/23/2006 | CN1823070A Salinosporamides and methods for use thereof |
| 08/23/2006 | CN1823036A Novel dibenzo[B,F]oxepine-10-carboxamides and pharmaceutical uses thereof |
| 08/23/2006 | CN1821250A 1H-pyranyl[3,4d][1,2,3] tri-azonyl-4-ketonic compound, synthetic method and use |
| 08/23/2006 | CN1821239A Process for preparing oxa anthracene compound |
| 08/23/2006 | CN1271074C Ramification of chirality multi ring quinoline tetroxide, preparation method and usage |
| 08/23/2006 | CN1271073C Crystalline anti-cholinergic tiotropium crystal |
| 08/23/2006 | CN1271068C Novel method for preparing olmesartan |
| 08/23/2006 | CN1271066C Aromatic dicarboxylic acid derivatives |
| 08/23/2006 | CN1271054C Urea compounds having muscarinic receptor antagonist activity |
| 08/23/2006 | CN1270707C Ophthalmic solution |
| 08/22/2006 | US7094805 Total synthesis of merrilactone A |
| 08/22/2006 | US7094790 containing a pyrrole ring, e.g., 4-{2-[2-(2-(R)-Methyl-pyrrolidin-1-yl)-ethyl]-benzothiazol-5-yl}-benzonitrile; useful for treating conditions and disorders related to memory and cognition processes, neurological processes, cardiovascular function, and body weight. |
| 08/22/2006 | US7094784 High affinity ligands for nociceptin receptor ORL-1 |
| 08/22/2006 | US7094783 Inhibitors of serine proteases; for therapy of thromboembolic disorder |
| 08/22/2006 | US7094368 Compounds in which selection and placement of substituents control wavelength and/or intensity of visible absorbance bands |
| 08/17/2006 | WO2006084941A2 Process for the preparation of irinotecan hydrochloride |
| 08/17/2006 | WO2006076646A3 Heteroaryl substituted quinolin-4-ylamine analogues |
| 08/17/2006 | WO2006000555A3 Novel unsaturated tetracyclic tetrahydrofuran derivatives |
| 08/17/2006 | WO2005107762A3 Certain chemical entities, compositions, and methods |
| 08/17/2006 | US20060183908 Heterocyclic compounds, methods of making them and their use in therapy |
| 08/17/2006 | US20060183906 Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-4-yl-amines as janus kinase inhibitors |
| 08/17/2006 | US20060183904 selective agonists of (MC-4R); obesity, diabetes, male and female sexual dysfunction, insulin resistance, osteoartritis; long duration of action, side effects reduction; stereoisomers |
| 08/17/2006 | US20060183784 Human growth hormone antagonists |
| 08/17/2006 | US20060183759 Tissue transglutaminase inhibitors |
| 08/17/2006 | US20060179585 Sulfonamide derviatives of polycyclic dyes used for analytical applications |
| 08/17/2006 | CA2591074A1 Preparation method |
| 08/16/2006 | EP1690863A1 Novel condensed imidazole derivative |
| 08/16/2006 | EP1690542A2 Pharmaceutical composition for the treatment of ovarian cancer |
| 08/16/2006 | EP1689753A1 Novel chemical compounds |
| 08/16/2006 | EP1689746A2 A process for aqueous milling of quinacridone pigments |
| 08/16/2006 | EP1689406A2 Heterocyclic inhibitors of mek and methods of use thereof |
| 08/16/2006 | EP1689400A2 Novel compound, corresponding compositions, preparation and/or treatment methods |
| 08/16/2006 | EP1689392A1 N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes |
| 08/16/2006 | EP1689387A2 Bicyclic inhibitors of mek and methods of use thereof |
| 08/16/2006 | EP1689233A2 Bicyclic inhibitors of mek and methods of use thereof |
| 08/16/2006 | EP1414821B1 Tricyclic epoxides |
| 08/16/2006 | EP0880523B1 Pyrazolopyrimidines as crf receptor antagonists |
| 08/16/2006 | EP0861236B2 Cyclic and heterocyclic n-substituted alpha-iminohydroxamic and carboxylic acids |
| 08/16/2006 | CN1820008A Substituted quinolin-4-ylamine analogues |
| 08/16/2006 | CN1817885A Production of galantamine |
| 08/16/2006 | CN1817864A Synthesis of enantiomerically pure amino-substituted fused bicyclic rings |
| 08/16/2006 | CN1817863A 3-substituted 1,2,3.4-tetrahydro-quinazine derivative, its synthesis and use |
| 08/16/2006 | CN1269822C Inhibitors of cruzipain and other cysteine proteases |
| 08/16/2006 | CN1269821C Polymorphs of an epothilone analog |
| 08/16/2006 | CN1269818C Lactam compounds and medicinal use thereof |
| 08/15/2006 | US7091356 Tumor necrosis factor, to inhibit phosphodiesterase in a mammal |
| 08/15/2006 | US7091351 Vanadium compounds for treating cancer |
| 08/15/2006 | US7091347 2-substituted amino-bicyclic pyridine and pyrimidine compounds; for treatment of inflammation, inflammatory bowel disease, Alzheimer's disease, Crohn's disease, multiple sclerosis and asthma |
| 08/15/2006 | US7091345 Tyrosine kinase inhibitor; anticancer agents; antiproliferative agents; antiinflammatory agents |
| 08/15/2006 | US7091223 Autoimmune diseases; anticancer agents |
| 08/15/2006 | US7091217 Chemokine receptor binding heterocyclic compounds |
| 08/15/2006 | US7091216 antagonists of the Cannabinoid-1 (CB1) receptor; treating obesity |
| 08/15/2006 | US7091213 Phosphorus-containing compounds and uses thereof |
| 08/15/2006 | US7091211 3-(aryl or heteroaryl)-4-((spiropiperidin-1-yl)alkyl)cyclopentyl compounds and stereisomers, used for prevention of lymphadenopathy associated virus infection, and delaying the onset of aquired immune deficiency syndrome |
| 08/15/2006 | US7091200 adrenoceptor or G-protein coupled receptors inhibitors such as 3-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-6,7-dimethoxy-2H-benzo[1,2,4]-thiadiazine-1,1-dioxide and carriers, used for prophylaxis of urogenital disorders, or as analgesics |
| 08/15/2006 | CA2236896C 1-arylsulphonyl, aryl(thio)carbonyl pyridazino derivatives and methods of preparation |
| 08/15/2006 | CA2150805C Antiallergic imidazo[1,2-a](pyrrolo, thieno or furano)[2,3-d]azepine derivatives |
| 08/10/2006 | WO2006083271A2 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 08/10/2006 | WO2006082409A2 Tricyclic cytoprotective compounds |
| 08/10/2006 | WO2006082279A1 Process for the manufacturing of 7-ethyl-10-hydroxy camptothecin |
| 08/10/2006 | WO2006082001A1 Heterocyclic substituted phenyl methanones as inhibitors of the glycine transporter 1 |
| 08/10/2006 | WO2006065828A3 Novel farnesyl protein transferase inhibitors and their use to treat cancer |
| 08/10/2006 | WO2006012310A3 Carbazole derivatives for treating polycystic kidney disease |
| 08/10/2006 | US20060178514 Novel benzylamine derivatives as CETP inhibitors |
| 08/10/2006 | US20060178392 CCI-779 polymorph and use thereof |
| 08/10/2006 | US20060178376 Novel process for the preparation of hexacyclic compounds |
| 08/10/2006 | US20060178363 Tetrahydropyranyl cyclopentyl heterocyclic amide modulators of chemokine receptor activity |
| 08/10/2006 | US20060178362 Substituted heterocyle fused gamma-carbolines |
| 08/10/2006 | US20060178355 Analogs of leucascandrolide A |
| 08/10/2006 | CA2596736A1 Tricyclic cytoprotective compounds |
| 08/10/2006 | CA2596636A1 Heterocyclic substituted phenyl methanones as inhibitors of the glycine transporter 1 |
| 08/10/2006 | CA2591081A1 Process for the manufacturing of 7-ethyl-10-hydroxy camptothecin |
| 08/10/2006 | CA2566809A1 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 08/09/2006 | EP1688418A2 Chemokine receptor antagonists and methods of use thereof |
| 08/09/2006 | EP1687312A1 Dual molecules containing peroxy derivative, the synthesis and therapeutic applications thereof |
| 08/09/2006 | EP1687311A1 Novel compounds |